- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Locally advanced or metastatic breast cancer
- Meeting Date: November 2020
- Public Summary Document (PSD) November 2020 PBAC Meeting - (PDF 1326KB)
- Public Summary Document (PSD) November 2020 PBAC Meeting - (Word 289KB)
Ribociclib – November 2020
Ribociclib: Tablet 200 mg: Kisqali®
Last updated
5 March 2021